Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Immunotherapy
Page 1 of 5 ( 223 items )
<<
1
2
3
4
5
>>
1
Meta-analysis of the efficacy of neoadjuvant immunotherapy combined with radiotherapy and chemotherapy for locally advanced rectal cancer
11/14/2025 12:56:24 AM |
Browse: 13 |
Download: 62
2
Prognostic value of immune-inflammation and nutritional indices in advanced hepatocellular carcinoma patients receiving immunotherapy with compound Kushen injection
7/14/2025 12:56:06 PM |
Browse: 62 |
Download: 312
3
Programmed cell death 1 inhibitor sintilimab plus S-1 and gemcitabine for liver metastatic pancreatic ductal adenocarcinoma
12/11/2024 10:19:43 AM |
Browse: 95 |
Download: 548
4
Immunotherapy for metastatic gastric cancer
10/30/2024 2:58:47 PM |
Browse: 110 |
Download: 475
5
Impact of liver metastasis on immunotherapy in gastric carcinoma
9/28/2024 4:34:19 AM |
Browse: 128 |
Download: 505
6
Immunotherapy for gastric cancer and liver metastasis: Is it time to bid farewell
8/16/2024 3:30:03 PM |
Browse: 161 |
Download: 555
7
Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors
8/16/2024 8:03:14 AM |
Browse: 186 |
Download: 505
8
Impact of immunotherapy on liver metastasis
7/22/2024 11:57:17 AM |
Browse: 173 |
Download: 495
9
Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma
7/16/2024 6:17:55 AM |
Browse: 197 |
Download: 619
10
Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies
6/25/2024 10:41:21 AM |
Browse: 148 |
Download: 540
11
Comparative effectiveness of immunotherapy and chemotherapy in patients with metastatic colorectal cancer stratified by microsatellite instability status
4/22/2024 9:51:56 AM |
Browse: 182 |
Download: 668
12
Immune checkpoint inhibitor-associated gastritis: Patterns and management
4/12/2024 4:45:44 PM |
Browse: 210 |
Download: 731
13
Approaches and challenges in cancer immunotherapy pathways
3/22/2024 11:48:13 AM |
Browse: 195 |
Download: 698
14
Revolutionizing gastric cancer treatment: The potential of immunotherapy
1/26/2024 7:56:28 AM |
Browse: 331 |
Download: 862
15
Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023)
10/27/2023 3:28:49 PM |
Browse: 384 |
Download: 1454
16
Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
7/10/2023 8:58:21 AM |
Browse: 394 |
Download: 1070
17
Immunotherapy for advanced gastric cancer
6/20/2023 11:28:13 AM |
Browse: 422 |
Download: 1048
18
Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers
6/12/2023 8:16:26 AM |
Browse: 351 |
Download: 919
19
Immunotherapy for recurrent hepatocellular carcinoma
4/14/2023 1:45:13 PM |
Browse: 398 |
Download: 993
20
“Cold” colorectal cancer faces a Bottleneck in immunotherapy
2/15/2023 12:44:08 AM |
Browse: 425 |
Download: 1029
21
Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature
11/23/2022 9:44:45 AM |
Browse: 416 |
Download: 1439
22
Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review
11/21/2022 4:25:35 AM |
Browse: 535 |
Download: 1247
23
Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
11/17/2022 4:40:53 AM |
Browse: 636 |
Download: 1482
24
Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
11/10/2022 9:21:28 AM |
Browse: 523 |
Download: 1568
25
Favorable response of primary pulmonary lymphoepithelioma-like carcinoma to sintilimab combined with chemotherapy: A case report
10/27/2022 4:55:05 AM |
Browse: 489 |
Download: 1289
26
Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China
10/27/2022 4:55:05 AM |
Browse: 594 |
Download: 1552
27
Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
10/27/2022 3:05:58 AM |
Browse: 454 |
Download: 1570
28
Longest survival with primary intracranial malignant melanoma: A case report and literature review
10/21/2022 2:24:59 AM |
Browse: 517 |
Download: 1338
29
Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports
10/21/2022 2:24:59 AM |
Browse: 498 |
Download: 1281
30
Autoimmune encephalitis with posterior reversible encephalopathy syndrome: A case report
10/21/2022 2:24:59 AM |
Browse: 496 |
Download: 1245
31
Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
10/14/2022 12:54:50 PM |
Browse: 607 |
Download: 2236
32
New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
10/14/2022 8:30:45 AM |
Browse: 521 |
Download: 1323
33
Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
9/29/2022 9:17:29 AM |
Browse: 530 |
Download: 1312
34
Malignant peritoneal mesothelioma with massive ascites as the first symptom: A case report
9/27/2022 1:00:18 PM |
Browse: 994 |
Download: 1477
35
Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
9/23/2022 10:13:16 AM |
Browse: 591 |
Download: 1487
36
Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast
9/22/2022 6:32:13 AM |
Browse: 487 |
Download: 1190
37
Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: A case report
9/16/2022 11:52:44 AM |
Browse: 550 |
Download: 1327
38
Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer
9/9/2022 12:48:14 PM |
Browse: 523 |
Download: 1834
39
Implication of gut microbiome in immunotherapy for colorectal cancer
9/9/2022 12:48:14 PM |
Browse: 541 |
Download: 1599
40
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
9/9/2022 12:48:14 PM |
Browse: 545 |
Download: 1345
41
Advances in postoperative adjuvant therapy for primary liver cancer
9/9/2022 12:48:14 PM |
Browse: 608 |
Download: 1703
42
Treatment of gastric carcinoma with lymphoid stroma by immunotherapy: A case report
8/26/2022 9:54:53 AM |
Browse: 551 |
Download: 1704
43
Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma
8/26/2022 9:51:35 AM |
Browse: 490 |
Download: 1238
44
Paroxysmal speech disorder as the initial symptom in a young adult with anti-N-methyl-D-aspartate receptor encephalitis: A case report
8/16/2022 1:35:32 AM |
Browse: 434 |
Download: 1342
45
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
8/1/2022 9:20:54 AM |
Browse: 584 |
Download: 1531
46
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
7/27/2022 2:48:53 AM |
Browse: 574 |
Download: 1260
47
Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
7/27/2022 2:48:53 AM |
Browse: 527 |
Download: 1076
48
Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy
7/22/2022 9:38:18 AM |
Browse: 664 |
Download: 1568
49
Nanomedicine approaches for treatment of hematologic and oncologic malignancies
7/22/2022 9:38:18 AM |
Browse: 610 |
Download: 1433
50
Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
7/18/2022 9:47:46 AM |
Browse: 736 |
Download: 1455
Page 1 of 5 ( 223 items )
<<
1
2
3
4
5
>>
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345